TYRA Tyra Biosciences19.85-1.08 (-5.2%)
TYRA Tyra Biosciences23.46-0.08 (-0.3%)
TYRA Tyra Biosciences20.66-6.07 (-22.7%)
Premarket Decliner
TYRA Tyra Biosciences26.73-1.92-6.7%
Premarket:20.00-6.73 (-25.2%)
Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
PRNewswireWed, 9-Sep 7:00 AM
TYRA Tyra Biosciences27.49-1.16 (-4.1%)